Particle carriers for combating multidrug-resistant cancer

ACS Nano

Volumn 7, Issue 11, 2013, Pages 9512-9517

  Yan, Yan ^a   Björnmalm, Mattias ^a   Caruso, Frank ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CO DELIVERIES; DRUG RESISTANCE; MULTIDRUG RESISTANCE; PARTICLE CARRIERS; POTENTIAL BENEFITS; TREATMENT FAILURE; TUMOR HETEROGENEITY;

DISEASES;

TUMORS;

ANTINEOPLASTIC AGENT; DRUG CARRIER; SMALL INTERFERING RNA;

ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG RESISTANCE; ENDOCYTOSIS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MULTIDRUG RESISTANCE; NANOMEDICINE; NEOPLASM; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOCYTOSIS; HUMANS; MICE; NANOMEDICINE; NEOPLASM TRANSPLANTATION; NEOPLASMS; RNA, SMALL INTERFERING; TUMOR MICROENVIRONMENT;

EID: 84888880735     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn405632s     Document Type: Review

References (28)

1. Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation Cell 2011, 144, 646-674
2. Chabner, B. A.; Roberts, T. G., Jr. Chemotherapy and the War on Cancer Nat. Rev. Cancer 2005, 5, 65-72 (Pubitemid 40052326)
3. Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Targeting Multidrug Resistance in Cancer Nat. Rev. Drug Discovery 2006, 5, 219-234 (Pubitemid 43336035)
4. Fletcher, J. I.; Haber, M.; Henderson, M. J.; Norris, M. D. ABC Transporters in Cancer: More than Just Drug Efflux Pumps Nat. Rev. Cancer 2010, 10, 147-156
5. Wang, A. Z.; Langer, R.; Farokhzad, O. C. Nanoparticle Delivery of Cancer Drugs Annu. Rev. Med. 2012, 63, 185-198
6. Deng, Z. J.; Morton, S. W.; Ben-Akiva, E.; Dreaden, E. C.; Shopsowitz, K. E.; Hammond, P. T. Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment ACS Nano 2013, 10.1021/nn4047925
7. Turner, N. C.; Reis-Filho, J. S. Genetic Heterogeneity and Cancer Drug Resistance Lancet Oncol. 2012, 13, e178-185
8. Wang, D.; Lippard, S. J. Cellular Processing of Platinum Anticancer Drugs Nat. Rev. Drug Discovery 2005, 4, 307-320 (Pubitemid 41130944)
9. Rabik, C. A.; Dolan, M. E. Molecular Mechanisms of Resistance and Toxicity Associated with Platinating Agents Cancer Treat. Rev. 2007, 33, 9-23 (Pubitemid 46137553)
10. Yasuda, H.; Kobayashi, S.; Costa, D. B. EGFR Exon 20 Insertion Mutations in Non-Small-Cell Lung Cancer: Preclinical Data and Clinical Implications Lancet Oncol. 2012, 13, e23-31
11. Brosh, R.; Rotter, V. When Mutants Gain New Powers: News from the Mutant P53 Field Nat. Rev. Cancer 2009, 9, 701-713
12. Meacham, C. E.; Morrison, S. J. Tumour Heterogeneity and Cancer Cell Plasticity Nature 2013, 501, 328-337
13. Bedard, P. L.; Hansen, A. R.; Ratain, M. J.; Siu, L. L. Tumour Heterogeneity in the Clinic Nature 2013, 501, 355-364
14. Baylin, S. B.; Jones, P. A. A Decade of Exploring the Cancer Epigenome: Biological and Translational Implications Nat. Rev. Cancer 2011, 11, 726-734
15. Spencer, S. L.; Gaudet, S.; Albeck, J. G.; Burke, J. M.; Sorger, P. K. Non-Genetic Origins of Cell-to-Cell Variability in Trail-Induced Apoptosis Nature 2009, 459, 428-432
16. Junttila, M. R.; de Sauvage, F. J. Influence of Tumour Micro-Environment Heterogeneity on Therapeutic Response Nature 2013, 501, 346-354
17. Redig, A. J.; McAllister, S. S. Breast Cancer as a Systemic Disease: A View of Metastasis J. Intern. Med. 2013, 274, 113-126
18. Gao, Z.; Zhang, L.; Sun, Y. Nanotechnology Applied To Overcome Tumor Drug Resistance J. Controlled Release 2012, 162, 45-55
19. Chen, Y.; Bathula, S. R.; Li, J.; Huang, L. Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer J. Biol. Chem. 2010, 285, 22639-22650
20. Zhang, Y.; Schwerbrock, N. M.; Rogers, A. B.; Kim, W. Y.; Huang, L. Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSLC Mol. Ther. 2013, 21, 1559-1569
21. Taratula, O.; Kuzmov, A.; Shah, M.; Garbuzenko, O. B.; Minko, T. Nanostructured Lipid Carriers as Multifunctional Nanomedicine Platform for Pulmonary Co-Delivery of Anticancer Drugs and siRNA J. Controlled Release 2013, 171, 349-357
22. Yan, Y.; Ochs, C. J.; Such, G. K.; Heath, J. K.; Nice, E. C.; Caruso, F. Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules Adv. Mater. 2010, 22, 5398-5403
23. Yan, Y.; Björnmalm, M.; Caruso, F. Assembly of Layer-by-Layer Particles and Their Interactions with Biological Systems Chem. Mater. 2013, 10.1021/cm402126n
24. Duan, R.; Xia, F.; Jiang, L. Constructing Tunable Nanopores and Their Application in Drug Delivery ACS Nano 2013, 7, 8344-8349
25. Meng, H.; Mai, W. X.; Zhang, H.; Xue, M.; Xia, T.; Lin, S.; Wang, X.; Zhao, Y.; Ji, Z.; Zink, J. I. et al. Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo ACS Nano 2013, 7, 994-1005
26. Chauhan, V. P.; Jain, R. K. Strategies for Advancing Cancer Nanomedicine Nat. Mater. 2013, 12, 958-962
27. Yamada, K. M.; Cukierman, E. Modeling Tissue Morphogenesis and Cancer in 3D Cell 2007, 130, 601-610 (Pubitemid 47268064)
28. van der Meer, A. D.; van den Berg, A. Organs-on-Chips: Breaking the in Vitro Impasse Integr. Biol. 2012, 4, 461-470